APA

Galasko G. T., Bao Y., Broomfield S. J., Hooper N. M., Turner A. J. & Larner J. (19950907). Circulating factors and insulin resistance. I. A novel myoinositol 1,2-cyclic phosphate phosphoglycan insulin antagonist from human plasma is elevated in noninsulin-dependent diabetes mellitus. : The Journal of clinical endocrinology and metabolism.

Chicago

Galasko G T, Bao Y, Broomfield S J, Hooper N M, Turner A J and Larner J. 19950907. Circulating factors and insulin resistance. I. A novel myoinositol 1,2-cyclic phosphate phosphoglycan insulin antagonist from human plasma is elevated in noninsulin-dependent diabetes mellitus. : The Journal of clinical endocrinology and metabolism.

Harvard

Galasko G. T., Bao Y., Broomfield S. J., Hooper N. M., Turner A. J. and Larner J. (19950907). Circulating factors and insulin resistance. I. A novel myoinositol 1,2-cyclic phosphate phosphoglycan insulin antagonist from human plasma is elevated in noninsulin-dependent diabetes mellitus. : The Journal of clinical endocrinology and metabolism.

MLA

Galasko G T, Bao Y, Broomfield S J, Hooper N M, Turner A J and Larner J. Circulating factors and insulin resistance. I. A novel myoinositol 1,2-cyclic phosphate phosphoglycan insulin antagonist from human plasma is elevated in noninsulin-dependent diabetes mellitus. : The Journal of clinical endocrinology and metabolism. 19950907.